vs
Side-by-side financial comparison of SYNAPTICS Inc (SYNA) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($311.4M vs $302.5M, roughly 1.0× SYNAPTICS Inc). Bio-Techne runs the higher net margin — 16.4% vs -4.9%, a 21.3% gap on every dollar of revenue. On growth, SYNAPTICS Inc posted the faster year-over-year revenue change (13.2% vs -1.5%). Over the past eight quarters, SYNAPTICS Inc's revenue compounded faster (12.9% CAGR vs 1.3%).
Synaptics, Inc. is an American neural network technologies and computer-to-human interface devices development company based in San Jose, California. It develops touchpads and fingerprint biometrics technology for computer laptops; touch, display driver, and fingerprint biometrics technology for smartphones; and touch, video and far-field voice, low-power AI processors, and wireless technology for smart home devices, wearables, and automobiles. Synaptics sells its products to original equipme...
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
SYNA vs TECH — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $302.5M | $311.4M |
| Net Profit | $-14.8M | $51.0M |
| Gross Margin | 43.5% | 66.9% |
| Operating Margin | -5.0% | 24.2% |
| Net Margin | -4.9% | 16.4% |
| Revenue YoY | 13.2% | -1.5% |
| Net Profit YoY | -922.2% | 126.0% |
| EPS (diluted) | $-0.38 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $311.4M | ||
| Q4 25 | $302.5M | $295.9M | ||
| Q3 25 | $292.5M | — | ||
| Q2 25 | $282.8M | $317.0M | ||
| Q1 25 | $266.6M | $316.2M | ||
| Q4 24 | $267.2M | $297.0M | ||
| Q3 24 | $257.7M | $289.5M | ||
| Q2 24 | $247.4M | $306.1M |
| Q1 26 | — | $51.0M | ||
| Q4 25 | $-14.8M | $38.0M | ||
| Q3 25 | $-20.6M | — | ||
| Q2 25 | $-4.7M | $-17.7M | ||
| Q1 25 | $-21.8M | $22.6M | ||
| Q4 24 | $1.8M | $34.9M | ||
| Q3 24 | $-23.1M | $33.6M | ||
| Q2 24 | $208.3M | $40.6M |
| Q1 26 | — | 66.9% | ||
| Q4 25 | 43.5% | 64.6% | ||
| Q3 25 | 42.6% | — | ||
| Q2 25 | 43.0% | 62.7% | ||
| Q1 25 | 43.4% | 67.9% | ||
| Q4 24 | 45.7% | 65.3% | ||
| Q3 24 | 46.9% | 63.2% | ||
| Q2 24 | 45.8% | 66.4% |
| Q1 26 | — | 24.2% | ||
| Q4 25 | -5.0% | 18.4% | ||
| Q3 25 | -7.9% | — | ||
| Q2 25 | -8.6% | -7.5% | ||
| Q1 25 | -9.9% | 12.2% | ||
| Q4 24 | -5.7% | 16.0% | ||
| Q3 24 | -11.0% | 13.8% | ||
| Q2 24 | -12.6% | 15.0% |
| Q1 26 | — | 16.4% | ||
| Q4 25 | -4.9% | 12.8% | ||
| Q3 25 | -7.0% | — | ||
| Q2 25 | -1.7% | -5.6% | ||
| Q1 25 | -8.2% | 7.1% | ||
| Q4 24 | 0.7% | 11.7% | ||
| Q3 24 | -9.0% | 11.6% | ||
| Q2 24 | 84.2% | 13.3% |
| Q1 26 | — | $0.32 | ||
| Q4 25 | $-0.38 | $0.24 | ||
| Q3 25 | $-0.53 | — | ||
| Q2 25 | $-0.13 | $-0.11 | ||
| Q1 25 | $-0.56 | $0.14 | ||
| Q4 24 | $0.05 | $0.22 | ||
| Q3 24 | $-0.58 | $0.21 | ||
| Q2 24 | $5.28 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $437.4M | $209.8M |
| Total DebtLower is stronger | $836.0M | — |
| Stockholders' EquityBook value | $1.4B | $2.1B |
| Total Assets | $2.6B | $2.6B |
| Debt / EquityLower = less leverage | 0.60× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $209.8M | ||
| Q4 25 | $437.4M | $172.9M | ||
| Q3 25 | $459.9M | — | ||
| Q2 25 | $452.5M | $162.2M | ||
| Q1 25 | $421.4M | $140.7M | ||
| Q4 24 | $596.1M | $177.5M | ||
| Q3 24 | $853.6M | $187.5M | ||
| Q2 24 | $876.9M | $152.9M |
| Q1 26 | — | — | ||
| Q4 25 | $836.0M | $260.0M | ||
| Q3 25 | $835.4M | — | ||
| Q2 25 | $834.8M | $346.0M | ||
| Q1 25 | $834.2M | $330.0M | ||
| Q4 24 | $832.5M | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | $983.5M | $319.0M |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.4B | $2.0B | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | $1.9B | ||
| Q1 25 | $1.4B | $2.0B | ||
| Q4 24 | $1.4B | $2.1B | ||
| Q3 24 | $1.5B | $2.1B | ||
| Q2 24 | $1.5B | $2.1B |
| Q1 26 | — | $2.6B | ||
| Q4 25 | $2.6B | $2.5B | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.6B | $2.6B | ||
| Q1 25 | $2.6B | $2.6B | ||
| Q4 24 | $2.5B | $2.7B | ||
| Q3 24 | $2.8B | $2.7B | ||
| Q2 24 | $2.8B | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | 0.60× | 0.13× | ||
| Q3 25 | 0.60× | — | ||
| Q2 25 | 0.60× | 0.18× | ||
| Q1 25 | 0.60× | 0.16× | ||
| Q4 24 | 0.60× | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | 0.67× | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.8M | — |
| Free Cash FlowOCF − Capex | $18.2M | — |
| FCF MarginFCF / Revenue | 6.0% | — |
| Capex IntensityCapex / Revenue | 3.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $154.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $29.8M | — | ||
| Q3 25 | $30.2M | — | ||
| Q2 25 | $57.2M | $98.2M | ||
| Q1 25 | $73.4M | $41.1M | ||
| Q4 24 | $22.8M | $84.3M | ||
| Q3 24 | $-11.4M | $63.9M | ||
| Q2 24 | $65.0M | $75.5M |
| Q1 26 | — | — | ||
| Q4 25 | $18.2M | — | ||
| Q3 25 | $18.0M | — | ||
| Q2 25 | $50.6M | $93.3M | ||
| Q1 25 | $68.0M | $31.0M | ||
| Q4 24 | $18.1M | $77.5M | ||
| Q3 24 | $-20.5M | $54.7M | ||
| Q2 24 | $57.3M | $57.5M |
| Q1 26 | — | — | ||
| Q4 25 | 6.0% | — | ||
| Q3 25 | 6.2% | — | ||
| Q2 25 | 17.9% | 29.4% | ||
| Q1 25 | 25.5% | 9.8% | ||
| Q4 24 | 6.8% | 26.1% | ||
| Q3 24 | -8.0% | 18.9% | ||
| Q2 24 | 23.2% | 18.8% |
| Q1 26 | — | — | ||
| Q4 25 | 3.8% | — | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | 2.3% | 1.5% | ||
| Q1 25 | 2.0% | 3.2% | ||
| Q4 24 | 1.8% | 2.3% | ||
| Q3 24 | 3.5% | 3.2% | ||
| Q2 24 | 3.1% | 5.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | 12.67× | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | 0.31× | 1.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SYNA
| Enterprise And Automotive Product Applications | $161.1M | 53% |
| Internet Of Things Product Applications | $93.2M | 31% |
| Mobile Product Applications | $48.2M | 16% |
TECH
| Protein Sciences segment revenue | $226.2M | 73% |
| Diagnostics and Spatial Biology segment revenue | $85.6M | 27% |
| Other revenue (1) | $5.4M | 2% |
